Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy.

rocilinostat (ACY-1215) - Regenacy

http://www.ncbi.nlm.nih.gov/pubmed/39979078

Benyan Lu; Binbin Cheng; Chengpeng Tao; Congcong Xu; Feng Jiang; Hailiu Liang; Haiqi He; Jianjun Chen; Shuqing Li; Ting Liu; Wanyi Pan; Xiaopeng Peng; Ying Hu; Zetao Qi; Zhihao Hu

Feb 21, 2025